Clarins’ buyback succeeds
This article was originally published in The Rose Sheet
Executive SummaryFinanciére FC, a holding company owned by the Courtin-Clarins family, has bought back enough shares to delist Groupe Clarins from the Paris Bourse, French market regulator Autorité des Marchés Financiers (AMF) says in Sept. 24 release. At close of the buyback offer Sept. 16, Financiére FC reportedly owned 96.44% of Clarins' capital and 97.2% of voting rights, clearing 95% threshold required by AMF. Consistent with price set when buyback plan was announced earlier this year, company will purchase remaining 2.21% of Clarins capital for €55.50 per share. Clarins brothers said roughly $1.17 billion would be invested in taking company private, a move that will grant it the stability needed to execute its strategic vision (1"The Rose Sheet" Aug. 11, 2008, p. 5)
You may also be interested in...
Almost a year after acquiring Loxo Oncology, Lilly is combining its Lilly Research Laboratories staff with a group headed by three top Loxo execs to lead cancer R&D and business development.
Tech Companies Grappling With A Brave New World Of Regulations While Developing Digital-Health Products
Software firms interested in the digital-health arena are engaging US FDA more and bolstering their regulatory credentials to navigate an unfamiliar regulatory landscape, industry experts tell Medtech Insight.